Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Orano Med LLC
Orano Med LLC
Bayer
The Methodist Hospital Research Institute
OncoTherapy Science, Inc.
General Oncology, Inc.
OncoNano Medicine, Inc.
M.D. Anderson Cancer Center
UNC Lineberger Comprehensive Cancer Center
Ono Pharmaceutical Co. Ltd
Lyell Immunopharma, Inc.
National Cancer Institute (NCI)
Leap Therapeutics, Inc.
Dana-Farber Cancer Institute
Incyte Corporation
National Institutes of Health Clinical Center (CC)
Sun Pharma Advanced Research Company Limited
University of Louisville
Rutgers, The State University of New Jersey
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Pharmacyclics LLC.
Light Sciences LLC